BioBridgeXAll companies

Immunome Inc.

Pharmaceutical company · Bothell, Washington, United States · Nasdaq: IMNM

Immunome Inc. is a pharmaceutical company headquartered in Bothell, Washington, United States. Its earliest recorded incorporation is in 2006. Its shares trade on Nasdaq under the ticker IMNM. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $270,025 in total, most recently in 2008. It has reported private securities offerings to the US SEC, most recently $27 million sold in a notice filed in 2021.

Profile compiled from public records. Is this your company? Request a correction or update

Immunome at a glance

Typepharmaceutical company
HeadquartersBothell, Washington, United States
Earliest incorporation on record2006
Stock listingNasdaq: IMNM
SEC industryPharmaceutical Preparations
SEC CIK1472012

What does Immunome do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $270,025 in total (2008).

Private fundraising reported to the SEC

20 Form D notices; the most recent reported $27 million sold (2021).

Frequently asked questions about Immunome

Where is Immunome headquartered?

Immunome Inc. is headquartered in Bothell, Washington, United States.

What does Immunome do?

Immunome Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is Immunome a public company?

Yes. Immunome Inc. trades on Nasdaq under the ticker IMNM.

When was Immunome founded?

The earliest incorporation on record for Immunome Inc. is in 2006, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.